Article Text

Download PDFPDF
A microarray screen for novel candidate genes in coeliac disease pathogenesis
  1. B Diosdado1,
  2. M C Wapenaar1,
  3. L Franke1,
  4. K J Duran2,
  5. M J Goerres3,
  6. M Hadithi4,
  7. J B A Crusius5,
  8. J W R Meijer6,
  9. D J Duggan7,*,
  10. C J J Mulder4,
  11. F C P Holstege8,
  12. C Wijmenga1
  1. 1Complex Genetics Group, Department of Biomedical Genetics, University Medical Centre, Utrecht, the Netherlands
  2. 2Complex Genetics Group, and Genomics Laboratory, Department of Biomedical Genetics, University Medical Centre, Utrecht, the Netherlands
  3. 3Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, the Netherlands
  4. 4Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, the Netherlands, and Department of Gastroenterology, Free University Medical Centre, Amsterdam, the Netherlands
  5. 5Laboratory of Gastrointestinal Immunogenetics, Free University Medical Centre, Amsterdam, the Netherlands
  6. 6Department of Pathology, Rijnstate Hospital, Arnhem, the Netherlands
  7. 7National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, USA
  8. 8Genomics Laboratory, Department of Physiological Chemistry, University Medical Centre, Utrecht, the Netherlands
  1. Correspondence to:
    Professor C Wijmenga
    Department of Biomedical Genetics, Stratenum 2.117, University Medical Centre Utrecht, PO Box 80030, 3508 TA Utrecht, the Netherlands; t.n.wijmengamed.uu.nl

Abstract

Background and aims: The causative molecular pathways underlying the pathogenesis of coeliac disease are poorly understood. To unravel novel aspects of disease pathogenesis, we used microarrays to determine changes in gene expression of duodenal biopsies.

Methods: cDNA microarrays representing 19 200 genes were used to compare gene expression profiles of duodenal biopsies from 15 coeliac disease patients with villous atrophy (Marsh III) and seven control individuals with normal biopsies (Marsh 0). In addition, the specific effect of gluten was studied by comparing the expression profiles of Marsh III lesions of seven patients exposed to gluten with four patients on a gluten free diet.

Results: Comparing Marsh III with Marsh 0 lesions identified 109 genes that differed significantly (p<0.001) in expression levels between patients and controls. A large number of these genes have functions in proliferation and differentiation pathways and might be important for correct development of crypt-villous units. Alterations in these pathways may lead to the characteristic hyperplasia and villous atrophy seen in coeliac disease. The analyses also revealed 120 differentially expressed genes (p<0.005) when comparing patients on a gluten free diet with those exposed to gluten. These genes further strengthen our observation of increased cell proliferation in the presence of gluten.

Conclusions: Our study provides new candidate genes in the pathogenesis of coeliac disease. Based on our results, we hypothesise that villous atrophy in coeliac disease patients is due to failure in cell differentiation. These genes are involved in pathways not previously implicated in coeliac disease pathogenesis and they may provide new targets for therapy.

  • HLA, human leucocyte antigen
  • M, Marsh
  • Th, T helper
  • RT-PCR, reverse transcription-polymerase chain reaction
  • IFN, interferon
  • IL, interleukin
  • APC, antigen presenting cells
  • microarray
  • cell signalling
  • chip
  • expression profiling
  • gene expression
  • coeliac disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • * Present address: TGen, Translational Genomics Research Institute, Phoenix, AZ, USA

Linked Articles